Cetuximab for the treatment of metastatic colorectal cancer following failure of oxaliplatin-containing chemotherapy

This is an extract from the guidance and may be misleading if read alone. The complete guidance is available at guidance.nice.org.uk/ta150

Important information about this appraisal

This appraisal has been updated and replaced by NICE technology appraisal guidance 242.